NCT06084767View on ClinicalTrials.gov

68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

December 30, 2025

Conditions
Malignant TumorPositron Emission TomographyFibroblast Activation Protein Inhibitor
Interventions
DIAGNOSTIC_TEST

68Ga-TCR-FAPI PET/CT

A dose of 3.7 MBq/kg 68Ga-TCR-FAPI will be intravenously injected and PET examination will be carried out within the specified time.

Trial Locations (1)

Unknown

RECRUITING

Peking University Cancer Hospital, Beijing

All Listed Sponsors
collaborator

Peking University

OTHER

collaborator

Peking University Cancer Hospital & Institute

OTHER

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER